Fasudil, a Clinically Safe ROCK Inhibitor, Decreases Disease Burden in a CBL/CBL-B Deficiency-Driven Murine Model of Myeloproliferative Disorders
Hematology - United Kingdom
doi 10.1179/1607845415y.0000000031
Full Text
Open PDFAbstract
Available in full text
Categories
Date
July 15, 2015
Authors
Publisher
Informa UK Limited